Supplementary protection
LT - Gliukopiranozilu pakeistieji benzeno dariniai, vaistai, turintys šių junginių, jų panudojimas ir jų gamybos būdas
EN - GLUCOPYRANOSYL-SUBSTITUTED BENZOL DERIVATIVES, DRUGS CONTAINING SAID COMPOUNDS, THE USE THEREOF AND METHOD FOR THE PRODUCTION THEREOF
SPC
| (11) |
Number of the document |
C 1730131 |
| (68) |
Number of the document |
1730131
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2014 035 |
| (22) |
Date of filing the application |
2014-09-25 |
| (41) |
Date of publication of the application |
2014-10-27 |
|
Date of publication of SPC |
2015-06-25 |
| (24) |
Date of coming into effect of SPC |
2025-03-12 |
Applicant
| (71) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim,
DE
|
Grantee
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim,
DE
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/14/930, 2014-05-22
|
Calculated date of expiry of the SPC
| (94) |
2029-05-27 |
Name of the product protected by the basic patent
| (95) |
Empagliflozinum |
Paediatric extension
|
Request filed |
SPC extension granted until |
Request refused |
|
2024-07-30 |
2029-11-27 |
|
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-02-21 |
1 |
347.00
EUR
|
Next renewal fee
|
2026-03-12 |
Legal status
|
SPC term extension granted
|
|
